The dopamine transporter (DAT) is the major molecular target responsible for both the rewarding properties and abuse potential of cocaine and related psychostimulants. The homologous neurotransmitter transporters (NTs) for serotonin and norepinephrine, SERT and NET, are primary targets of antidepressant drugs. These integral membrane proteins couple the accumulation of neurotransmitter to the movement of sodium ions down their concentration gradient. Progress in the study of their molecular structure and transport mechanisms has been hampered by an inability to develop high-level expression systems for these proteins and the subsequent lack of sufficient functional, purified protein. Bacterial membrane proteins are generally more amenable to structural analysis and high-level expression than are their eukaryotic counterparts. We have recently identified an entire family of proteins in archaea and in bacteria (currently 73 proteins from 45 different organisms) that are homologous to DAT. The sequence identity to DAT for the most similar proteins is approximately 25 percent, making it very likely that they have a similar structure. Our strategy was to develop a high-level expression system with one or more of these proteins to obtain adequate amounts for direct structural studies. During the first 1.5 years of our Stage I Cutting-edge Basic Research Award (CEBRA), we have: a) cloned 17 of these genes from various bacterial and archaeal genomes, b) heterologously over-expressed 12 of these in the membrane of E. coil, c) shown that one of these gene products, TnaT, is a sodium-dependent tryptophan transporter, confirming that these genes encode proteins with functions similar to the NTs, and reaffirming their value as models for direct structural analysis, d) purified full-length TnaT from the membrane to near homogeneity in yields of approximately 0.6 mg/I culture, e) constructed a cysteine-less TnaT that is functional and expresses at near wild-type levels, and f) constructed strategically placed individual cysteine mutants that express and function normally. In this Stage II CEBRA proposal the specific aims are: 1) To identify residues within or very near the substrate binding site in TnaT, a sodium-dependent tryptophan transporter from Symbiobacterium thermophilum, using mass spectroscopic analysis of azido-tryptophan analogs photo-incorporated into TnaT. 2) To identify a drug-like inhibitor of TnaT by screening a combinatorial chemical library. 3) To identify solubilization conditions that preserve the structure and function of TnaT. 4) To establish conditions for functional reconstitution of TnaT into proteoliposomes. When these aims have been achieved, we will be in a position to choose a limited number of the bacterial transporters for use in crystallization trials as a step towards obtaining a high-resolution structure. Moreover, we will also be poised to pursue spectroscopic methods to dynamic structure. Success in either or both of these goals would revolutionize our structural understanding of the function of related human neurotransmitter transporters in away that is only a remote prospect through continued work on the eukaryotic transporters alone.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA017293-03
Application #
6946951
Study Section
Molecular, Cellular and Developmental Neurosciences 2 (MDCN)
Program Officer
Hillery, Paul
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
3
Fiscal Year
2005
Total Cost
$347,367
Indirect Cost
Name
Columbia University (N.Y.)
Department
Physiology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Stolzenberg, Sebastian; Li, Zheng; Quick, Matthias et al. (2017) The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state. J Biol Chem 292:7372-7384
LeVine, Michael V; Cuendet, Michel A; Khelashvili, George et al. (2016) Allosteric Mechanisms of Molecular Machines at the Membrane: Transport by Sodium-Coupled Symporters. Chem Rev 116:6552-87
Khelashvili, George; Schmidt, Solveig Gaarde; Shi, Lei et al. (2016) Conformational Dynamics on the Extracellular Side of LeuT Controlled by Na+ and K+ Ions and the Protonation State of Glu290. J Biol Chem 291:19786-99
Khelashvili, George; Weinstein, Harel (2015) Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops. Biochim Biophys Acta 1848:1765-74
Zehnpfennig, Britta; Wiriyasermkul, Pattama; Carlson, David A et al. (2015) Interaction of ?-Lipoic Acid with the Human Na+/Multivitamin Transporter (hSMVT). J Biol Chem 290:16372-82
Khelashvili, George; Doktorova, Milka; Sahai, Michelle A et al. (2015) Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes. Proteins 83:952-69
LeVine, Michael V; Weinstein, Harel (2014) NbIT--a new information theory-based analysis of allosteric mechanisms reveals residues that underlie function in the leucine transporter LeuT. PLoS Comput Biol 10:e1003603
Mondal, Sayan; Khelashvili, George; Weinstein, Harel (2014) Not just an oil slick: how the energetics of protein-membrane interactions impacts the function and organization of transmembrane proteins. Biophys J 106:2305-16
Malinauskaite, Lina; Quick, Matthias; Reinhard, Linda et al. (2014) A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters. Nat Struct Mol Biol 21:1006-12
Dehnes, Yvette; Shan, Jufang; Beuming, Thijs et al. (2014) Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation. Neurochem Int 73:4-15

Showing the most recent 10 out of 27 publications